Caldera Therapeutics erupts with $112.5M and a China-originated IBD bispecific
Article Title: Caldera Therapeutics erupts with $112.5M and a China-originated IBD bispecific Publication Date: January 14, 2026 Following the $3.2 billion sell-off of Morphic Therapeutic to Eli Lilly, Praveen Tipirneni has made a swift return to the industry with a…